Clearmind Medicine Announces DSMB Approval To Advance Phase 1/2 Trial Of CMND-100 Into Parts B And C, Marking First Dosing In Alcohol Use Disorder Patients

Benzinga Newsdesk www.benzinga.com Positive 88.6%

Neg 0% Neu 0% Pos 88.6%

Comments

No comments yet. Be the first!